July 2019
Volume 60, Issue 9
ARVO Annual Meeting Abstract  |   July 2019
Artificial intelligence: the algorithmic solution to retinal healthcare
Author Affiliations & Notes
  • Pearse Andrew Keane
    Moorfields Eye Hospital NHS Foundation Trust, London, ENGLAND, United Kingdom
    Institute of Ophthalmology, University College London, London, United Kingdom
  • Footnotes
    Commercial Relationships   Pearse Keane, Allergan (R), Bayer (R), DeepMind (C), Haag-Streit (R), Heidelberg Engineering (R), Novartis (R), Optos (R), Topcon (R), Zeiss (R)
  • Footnotes
    Support  United Kingdom National Institute for Health Research (NIHR) Clinician Scientist Award (NIHR-CS-2014-14-023).
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4769. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pearse Andrew Keane; Artificial intelligence: the algorithmic solution to retinal healthcare. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4769.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Ophthalmology is among the most technology-driven of the all the medical specialties, with treatments utilizing high-spec medical lasers and advanced microsurgical techniques, and diagnostics involving ultra-high resolution imaging. Ophthalmology is also at the forefront of many trailblazing research areas in healthcare, such as stem cell and gene therapies.

Moorfields Eye Hospital in London is the oldest eye hospital in the world, and one of the largest, with >700,000 patient visits every year. In July 2016, Moorfields announced a formal collaboration and data sharing agreement with DeepMind Health. This collaboration involves the sharing of >1,000,000 anonymised retinal scans with DeepMind to allow for the automated diagnosis of diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR).

In my presentation, I will describe the motivation - and urgent need - to apply deep learning to retinal healhcare, the processes required to establish a research collaboration between the NHS and a company like DeepMind, the goals of our research, and finally, why I believe that ophthalmology could be first branch of medicine to be fundamentally reinvented through the application of deep learning.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.